Top

Published in:

Open Access 01-12-2022 | Alzheimer's Disease | Meeting report

Recommendations for addressing the translational gap between experimental and clinical research on amyloid diseases

Authors: Miriam Solomon, Vito Foderà, Annette Eva Langkilde, Perry Elliott, Fabrizio Tagliavini, Trevor Forsyth, Oxana Klementieva, Vittorio Bellotti

Published in: Journal of Translational Medicine | Issue 1/2022

Abstract

This paper is a report of recommendations for addressing translational challenges in amyloid disease research. They were developed during and following an international online workshop organized by the LINXS Institute of Advanced Neutron and X-Ray Science in March 2021. Key suggestions include improving cross-cultural communication between basic science and clinical research, increasing the influence of scientific societies and journals (vis-à-vis funding agencies and pharmaceutical companies), improving the dissemination of negative results, and strengthening the ethos of science.

Perutz MF. Mutations make enzyme polymerize. Nature. 1997;385:773–5. https://doi.org/10.1038/385773a0.CrossRefPubMed

Buxbaum JN, Linke RP. A molecular history of the amyloidoses. J Mol Biol. 2012;421:142–59. https://doi.org/10.1016/j.jmb.2012.01.024.CrossRefPubMed

David A, Hawkins PN, Polydefkis M. Oligonucleotide drugs for transthyretin amyloidosis. N Engl J Med. 2018;37:2085–6. https://doi.org/10.1056/NEJMc1810994.CrossRef

Rapezzi C, Elliott P, Damy T, Nativi-Nicolau J, Berk JL, Velazquez EJ, et al. Efficacy of tafamidis in patients with hereditary and wild-type transthyretin amyloid cardiomyopathy. JACC: Heart Failure. 2021;9:115–23. https://doi.org/10.1016/j.jchf.2020.09.011.CrossRefPubMed

Gillmore JD, Gane E, Taubel J, Kao J, Fontana M, Maitland ML, et al. CRISPR-Cas9 In Vivo gene editing for transthyretin amyloidosis. N Engl J Med. 2021;385:493–502. https://doi.org/10.1056/NEJMoa2107454.CrossRefPubMed

Costa PP, Figueira AS, Bravo FR. Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc Natl Acad Sci. 1978;75:4499–503. https://doi.org/10.1073/pnas.75.9.4499.CrossRefPubMedPubMedCentral

Tampi RR, Forester BP, Agronin M. Aducanumab: evidence from clinical trial data and controversies. Drugs In Context. 2021;10:1–9. https://doi.org/10.7573/dic.2021-7-3.CrossRef

Solomon M. Making medical knowledge. 1st ed. Oxford: Oxford University Press; 2015.CrossRef

Merton RK. The Matthew effect in science. The reward and communication systems of science are considered. Science. 1968;159:56–63. https://doi.org/10.1126/science.159.3810.56.CrossRefPubMed

10.

Merton RK. The sociology of science: theoretical and empirical incvestigations. 4. Dr. Chicago: Univ. of Chicago Pr; 1974. ISBN: 9780226520926

11.

Longino HE. Science as social knowledge: values and objectivity in scientific inquiry. Princeton, N.J: Princeton University Press; 1990. https://doi.org/10.2307/j.ctvx5wbfz.

Title: Recommendations for addressing the translational gap between experimental and clinical research on amyloid diseases
Authors: Miriam Solomon
Vito Foderà
Annette Eva Langkilde
Perry Elliott
Fabrizio Tagliavini
Trevor Forsyth
Oxana Klementieva
Vittorio Bellotti
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Alzheimer's Disease
Alzheimer's Disease
Amyloidosis
Published in: Journal of Translational Medicine / Issue 1/2022
Electronic ISSN: 1479-5876
DOI: https://doi.org/10.1186/s12967-022-03420-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2022

Single-cell transcriptomic analysis reveals a novel cell state and switching genes during hepatic stellate cell activation in vitro

Host-microbiome interactions regarding peri-implantitis and dental implant loss

A narrative review of the moderating effects and repercussion of exercise intervention on osteoporosis: ingenious involvement of gut microbiota and its metabolites

Whole-exome sequencing identified mutational profiles of urothelial carcinoma post kidney transplantation

Propranolol as therapy for cerebral cavernous malformations: a cautionary note

Superior physical and mental health of healthy volunteers before and five years after mobilized stem cell donation

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials